Related Experiment Videos
Field trials with killed oral typhoid vaccines
Summary
Two oral typhus vaccines were tested in students. The vaccine from the German Democratic Republic showed borderline significant results, while the German Federal Republic vaccine did not yield significant findings, necessitating further trials.
Area of Science:
- Epidemiology
- Vaccinology
Background:
- Typhus fever remains a public health concern requiring effective preventative measures.
- Oral vaccines offer a potential alternative to injectable vaccines for infectious diseases.
Purpose of the Study:
- To evaluate the efficacy of two different killed oral typhus vaccines.
- To compare the impact of vaccines from the German Democratic Republic (GDR) and German Federal Republic (GFR) on typhoid fever morbidity.
Main Methods:
- A placebo-controlled field trial involving students aged 10-19 in urban areas of Santiago Province.
- Administration of GDR vaccine to 37,517 students and placebo to a control group over 18 months.
- Administration of GFR vaccine to 37,566 students and placebo to a control group over 7 months.
- Reliable diagnostic confirmation for all observed cases.
Main Results:
- The GDR vaccine group showed statistically significant, albeit borderline, differences in typhoid fever morbidity compared to its control group.
- The GFR vaccine group did not exhibit a significant difference in morbidity compared to its control group.
- The shorter observation period for the GFR vaccine limits definitive conclusions.
Conclusions:
- The GDR oral typhus vaccine demonstrated some efficacy, warranting further investigation.
- The GFR oral typhus vaccine's efficacy could not be conclusively determined due to the limited observation period.
- Further, more extensive field trials are necessary to definitively assess the effectiveness of these oral typhus vaccines.